Diagnosis and management of diabetic peripheral neuropathy

Diabetic Medicine

Volumn 13, Issue SUPPL. 1, 1996, Pages

  Ziegler, D ^a,b  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

diabetic peripheral neuropathy; diagnosis; epidemiology; glycaemic control; pathogenesis; staging; symptomatic treatment

Indexed keywords

CONFERENCE PAPER; DIABETES CONTROL; DIABETIC NEUROPATHY; PATHOGENESIS;

EID: 0030019728     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/dme.1996.13.s1.34     Document Type: Conference Paper

References (30)

1. Consensus statement. Report and recommendations of the San Antonio conference on diabetic neuropathy. Diabetes Care 1988; 11: 592-597.
2. Thomas PK. Painful diabetic neuropathy: mechanisms and treatment. Diab Nutr Metab 1994; 7: 359-368.
3. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Diabetes Care 1992; 15(suppl 3): 1080-1107.
4. Dyck PJ. Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 1988; 11: 21-32.
5. Dyck PJ, Kratz KM, Lehman KA, Karnes JL, Melton LJ III, O'Brien PC, et al. The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 1991; 41: 799-807.
6. Young MJ, Boulton AJM, Macleod AF, Williams DRR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36: 150-154.
7. Quantitative sensory testing: a consensus report from the Peripheral Neuropathy Association. Neurology 1993; 43: 1050-1052.
8. Ziegler D. Diagnosis, staging and epidemiology of diabetic peripheral neuropathy. Diab Nutr Metab 1994; 7: 342-348.
9. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: The Rochester Diabetic Neuropathy Study. Neurology 1993; 43: 817-824.
10. Veglio M, Sivieri R, The Neuropathy Study Group of the Italian Society for the Study of Diabetes, Piemonte affiliate. Prevalence of neuropathy in IDDM patients in Piemonte, Italy. Diabetes Care 1993; 16: 456-461.
11. Ziegler D, Gries FA; Mühlen H, Rathmann W, Spüler M, Lessmann F, the DiaCAN Multicenter Study Group. Prevalence and clinical correlates of cardiovascular autonomic and peripheral diabetic neuropathy in patients attending diabetes centers. Diab Metab 1993; 19: 143-151.
12. Reichard P, Nilsson B-Y, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993; 329: 304-309.
13. Amthor K-F, Dahl-Jørgensen K, Berg TJ, Skard Heier M, Sandvik L, Aagenaes Ø, Hanssen KF. The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo Study. Diabetologia 1994; 37: 579-584.
14. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 1995; 122: 561-568.
15. Ziegler D, Dannehl K, Wiefels K, Gries FA. Differential effects of near-normoglycaemia for 4 years on somatic nerve dysfunction and heart rate variation in Type 1 diabetic patients. Diabetic Med 1992; 9: 622-629.
16. Ziegler D, Mayer P, Mühlen H, Gries FA. The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1991; 34: 822-829.
17. Kennedy WR, Navarro X, Goetz FC, Sutherland DER, Najarian JS. Effects of pancreatic transplantation on diabetic neuropathy. New Engl J Med 1990; 15: 1031-1037.
18. Solders G, Tydén G, Persson A, Groth C-G. Improvement of nerve conduction in diabetic neuropathy. A follow-up study 4 yr after combined pancreatic and renal transplantation. Diabetes 1992; 41: 946-951.
19. Müller-Felber W, Landgraf F, Scheuer R, Wagner S, Reimers CD, Nusser J, et al. Diabetic neuropathy 3 years after successful pancreas and kidney transplantation. Diabetes 1993; 42: 1482-1486.
20. Cameron NE, Cotter MA. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diab Metab Rev 1994; 10: 189-224.
21. Frank RN. The aldose reductase controversy. Diabetes 1994; 43: 169-172.
22. Giugliano D, Acampora K, Marfella R, Di Maro G, De Rosa N, Misso L, et al. Tolrestat in the primary prevention of diabetic neuropathy. Diabetes Care 1995; 18: 536-541.
23. The gamma-linolenic acid multicenter trial group. Treatment of diabetic neuropathy with gamma-linolenic acid: Diabetes Care 1993; 16: 8-15.
24. Ziegler D, Hanefeld M, Ruhnau KJ, Meißner HP, Lobisch M, Schütte K, Gries FA, ALADIN Study Croup. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid. A 3-week randomized controlled trial (ALADIN Study). Diabetologia 1995; 38: in press.
25. Sindrup SH. Antidepressants in the treatment of diabetic neuropathy symptoms. Pharmacodynamic, kinetic, and genetic aspects. Dan Med Bull 1994; 41: 66-78.
26. Max MB, Lynch SA, Muir J, Shoaf SE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992; 326: 1250-1256.
27. ®): double blind crossover trial. Diabetologia 1969; 5: 215-218.
28. Stracke H, Meyer UE, Schumacher HE, Federlin K. Mexiletine in the treatment of diabetic neuropathy. Diabetes Care 1992; 15: 1550-1555.
29. The Capsaicin Study Group. Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. Arch Intern Med 1991; 151: 2225-2229.
30. Pfeifer MA, Ross DR, Schrage JP, Gelber DA, Schumer MP, Crain GM, et al. A highly successful and novel model for treatment of chronic painful diabetic peripheral neuropathy. Diabetes Care 1993; 16: 1103-1115.